advertisement
Kao JH 31
Showing records 1 to 25 | Display all abstracts from Kao JH107594 Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan
Liu CH
Hepatology international 2023; 17: 291-302
108154 Long-term durability of sustained virologic response for hepatitis C virus infection in solid organ transplant recipients receiving direct-acting antivirals
Liu CH
Journal of the Formosan Medical Association 2023; 122: 800-804
108068 Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection
Liu CH
Journal of clinical medicine 2023; 12:
107594 Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan
Peng CY
Hepatology international 2023; 17: 291-302
108068 Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection
Fang YJ
Journal of clinical medicine 2023; 12:
108154 Long-term durability of sustained virologic response for hepatitis C virus infection in solid organ transplant recipients receiving direct-acting antivirals
Chen YS
Journal of the Formosan Medical Association 2023; 122: 800-804
108068 Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection
Liu CJ
Journal of clinical medicine 2023; 12:
108154 Long-term durability of sustained virologic response for hepatitis C virus infection in solid organ transplant recipients receiving direct-acting antivirals
Tsai MK
Journal of the Formosan Medical Association 2023; 122: 800-804
107594 Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan
Liu CJ
Hepatology international 2023; 17: 291-302
108154 Long-term durability of sustained virologic response for hepatitis C virus infection in solid organ transplant recipients receiving direct-acting antivirals
Wang SS
Journal of the Formosan Medical Association 2023; 122: 800-804
107594 Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan
Chen CY
Hepatology international 2023; 17: 291-302
108068 Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection
Su TH; Huang SC
Journal of clinical medicine 2023; 12:
107594 Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan
Lo CC
Hepatology international 2023; 17: 291-302
108154 Long-term durability of sustained virologic response for hepatitis C virus infection in solid organ transplant recipients receiving direct-acting antivirals
Lee CY; Tsao CI
Journal of the Formosan Medical Association 2023; 122: 800-804
108068 Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection
Tseng TC
Journal of clinical medicine 2023; 12:
107594 Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan
Tseng KC
Hepatology international 2023; 17: 291-302
108154 Long-term durability of sustained virologic response for hepatitis C virus infection in solid organ transplant recipients receiving direct-acting antivirals
Liu CJ
Journal of the Formosan Medical Association 2023; 122: 800-804
108068 Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection
Wu JH
Journal of clinical medicine 2023; 12:
107594 Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan
Su PY; Su PY; Kao WY
Hepatology international 2023; 17: 291-302
108068 Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection
Chen PJ
Journal of clinical medicine 2023; 12:
108154 Long-term durability of sustained virologic response for hepatitis C virus infection in solid organ transplant recipients receiving direct-acting antivirals
Su TH
Journal of the Formosan Medical Association 2023; 122: 800-804
107594 Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan
Tsai MC
Hepatology international 2023; 17: 291-302
108068 Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection
Kao JH
Journal of clinical medicine 2023; 12:
108154 Long-term durability of sustained virologic response for hepatitis C virus infection in solid organ transplant recipients receiving direct-acting antivirals
Tseng TC; Huang SC
Journal of the Formosan Medical Association 2023; 122: 800-804
107594 Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan
Tung HD
Hepatology international 2023; 17: 291-302
